Profit before tax at DKK 54m, 8% above ABGSCe Growth in Greenland on track Strong quarter on insur...
We expect a solid Q2 report on 26 August with group sales growing 26% y/y to SEK 182m, driven by M&A...
Following BankNordik's Q2 2022 report, we lift 2022E-24E adjusted EPS by ~1%, primarily due to impro...
Redeye endorses Genovis entering into a service agreement with evitria AG for LC-MS analysis of reco...
Enersense’s Q2 results were known before the official release as the company disclosed preliminary f...
Redeye comments on Active Biotech's second quarter report and the rights issue that was simultaneous...
Redeye is disappointed by Isofol’s phase III AGENT trial failing to meet its primary ORR and key sec...
Q2 bjöd på fortsatt god efterfrågan från flertalet stora kunder, trots osäker makromiljö.
Profit before tax came in 8% above ABGSC Strong quarter in the insurance business Guidance for ’2...
Q2 NII, NCI and insurance income came in as expected.
Suominen reports Q2 results on Tue, Aug 9. We continue to expect q/q improvement over the weak Q1 re...
DT’s Q2 EBIT faced a significant decline due to low sales and increased costs.
Redeye comments on EG7 ahead of its Q2-results (due 23 August) where we expect stable performance dr...
CapMan reported Q2 EBIT of 14.1m, 11% above Refinitiv consensus.
Q2: weaker profitability on lower GM and higher opex Continues to ramp up e-com investments Double...
Fastighetsbolaget har haft ett turbulent år och vi noterar att aktien handlas långt under rapportera...
Detection Technology’s Q2 net sales came down less than we expected.
Redeye comments on Better Collective ahead of its Q2-report (due 23 August) where we expect the typi...
Redeye is updating its estimates and valuation of Invisio after the Q2 report, which came in weaker ...
Continued focus on a diversified loan book Top-notch ROE expected to normalise at ~9% Expected div...
